Background Image
Table of Contents Table of Contents
Previous Page  152 / 658 Next Page
Information
Show Menu
Previous Page 152 / 658 Next Page
Page Background

In addition to these

offices, Thermo Fisher

Scientific maintains

a network of represen-

tative organizations

throughout the world.

Africa

+43 1 333 5034 127

Australia

+61 2 8844 9500

Austria

+43 1 333 50340

Belgium

+32 2 482 30 30

Canada

+1 800 530 8447

China

+86 10 5850 3588

Denmark

+45 70 23 62 60

Europe-Other

+43 1 333 5034 127

France

+33 1 60 92 48 00

Germany

+49 6103 408 1014

India

+91 22 6742 9434

Italy

+39 02 950 591

Japan

+81 45 453 9100

Latin America

+1 608 276 5659

Middle East

+43 1 333 5034 127

Netherlands

+31 76 587 98 88

South Africa

+27 11 570 1840

Spain

+34 914 845 965

Sweden/Norway/

Finland

+46 8 556 468 00

Switzerland

+41 61 48784 00

UK

+44 1442 233555

USA

+1 800 532 4752

www.thermo.com

AN62561E 12/07S

Part of Thermo Fisher Scientific

Thermo Fisher Scientific,

San Jose, CA USA is ISO Certified.

Legal Notices

©2007 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. This information

is presented as an example of the capabilities of Thermo Fisher Scientific Inc. products. It is not intended to encourage use of these products in any manners

that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all

countries. Please consult your local sales representative for details.

View additional Thermo Scientific LC/MS application notes at:

www.thermo.com/appnotes

The increase in selectivity at a peak width setting

of 0.1 Da FWHM is due to the fact that Clenbuterol

is a chlorinated compound and thus the negative mass

deficiency can be used to eliminate interferents from the

urine matrix in SRM mode. This increased selectivity can

be achieved without detrimental loss of transmission.

Typically only a factor of two to three fold decrease in

peak area is observed between analyses performed at 0.7

and 0.1 Da FWHM, however, greater selectivity could

then be achieved.

The calibration curves for Clenbuterol concentrations

of between 0.1 to 100 pg/µL at resolution settings of 0.1

and 0.7 Da FWHM both demonstrate excellent linearity.

The calibration line at 0.7 Da FWHM showed a high

intercept due to chemical background in the urine blank.

This was significantly reduced by the use of high

resolution.

The use of higher resolution to increase selectivity

and precision could enable the limit of quantitation

of an assay to be lowered and achieves a higher degree

of confidence in identification of analytes in biological

matrices.

Table 2: Calculated standards at 0.1 Da FWHM

SAMPLE NAME AREA

CALC AMT UNITS %RSD

Urine blank

0.00

0.00

pg/L

Urine blank

0.00

0.00

pg/L

Cal 0.1 pg/L

11245.02

0.10

pg/L

0.2%

Cal 0.1 pg/L

11272.54

0.10

pg/L

0.2%

Cal 0.5 pg/L

41960.02

0.46

pg/L

1.1%

Cal 0.5 pg/L

42592.84

0.46

pg/L

1.1%

Cal 1 pg/L

90353.60

1.02

pg/L

3.4%

Cal 1 pg/L

94633.92

1.07

pg/L

3.4%

Cal 5 pg/L

435920.49

5.04

pg/L

0.4%

Cal 5 pg/L

438538.32

5.07

pg/L

0.4%

Cal 10 pg/L

893656.24

10.36

pg/L

0.9%

Cal 10 pg/L

904758.00

10.49

pg/L

0.9%

Cal 50 pg/L

4120496.02

47.90

pg/L

1.3%

Cal 50 pg/L

4195902.58

48.78

pg/L

.3%

Cal 100 pg/L

8667429.70

100.81

pg/L

0.5%

Cal 100 pg/L

8727427.54

101.50

pg/L

0.5%